Williams Imani M, Neerukonda Vamsee K, Stagner Anna M
David G. Cogan Laboratory of Ophthalmic Pathology, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA.
Ocul Oncol Pathol. 2022 Jun;8(2):93-99. doi: 10.1159/000521739. Epub 2022 Jan 24.
Cyclodestructive procedures, which target the nonpigmented epithelium of the ciliary body, have been utilized to treat recalcitrant glaucoma since the early 1930s. There are now various types of cyclophotocoagulation (CPC) available. The authors provide a retrospective description that details the histopathologic findings in 2 patients who underwent CPC for uncontrolled uveitic and neovascular glaucoma (NVG) with subsequent enucleation.
Two enucleated globes from 2 patients with secondary refractory glaucoma underwent cilioablative therapy: one with uveitic glaucoma and a remote history of micropulse transscleral CPC (MP-TSCPC) and the other with NVG and a recent history of traditional continuous transscleral CPC (CW-TSCPC). The clinical histories are summarized, and light microscopy reviewed for degree of coagulative necrosis and inflammation of the ciliary body and surrounding structures, as well as the underlying pathology of the glaucoma.
Both patients ultimately experienced pain and vision loss with either a recrudescence of elevated intraocular pressure or inflammatory hypotony and subsequently underwent enucleation of the affected eye. One globe was enucleated shortly after CW-TSCPC and found to have near full-thickness coagulative necrosis of the pigmented and nonpigmented ciliary epithelium and ciliary muscle as well as necrosis of adjacent nontarget tissues with fibrin in the anterior chamber. The second patient underwent enucleation many months after MP-TSCPC with partial healing fibrosis of the ciliary body and some remaining viable ciliary processes. The histopathologic findings post-CPC may vary based on the method used and evolve over time; additional study is needed.
自20世纪30年代初以来,针对睫状体无色素上皮的睫状体破坏手术已被用于治疗顽固性青光眼。目前有多种类型的睫状体光凝术(CPC)。作者提供了一项回顾性描述,详细介绍了2例因葡萄膜炎性和新生血管性青光眼(NVG)控制不佳而接受CPC治疗并随后行眼球摘除术患者的组织病理学发现。
来自2例继发性难治性青光眼患者的2个摘除眼球接受了睫状体破坏治疗:1例为葡萄膜炎性青光眼,有微脉冲经巩膜CPC(MP-TSCPC)的远期病史;另1例为NVG,有传统连续经巩膜CPC(CW-TSCPC)的近期病史。总结了临床病史,并通过光学显微镜检查了睫状体及周围结构的凝固性坏死程度和炎症情况,以及青光眼的潜在病理改变。
两名患者最终均出现疼痛和视力丧失,眼压升高复发或炎症性低眼压,随后接受了患眼摘除术。1个眼球在CW-TSCPC后不久被摘除,发现色素性和无色素性睫状体上皮及睫状肌几乎全层凝固性坏死,以及前房内有纤维蛋白的相邻非靶组织坏死。第二名患者在MP-TSCPC后数月接受了眼球摘除术,睫状体有部分愈合纤维化,一些睫状突仍存活。CPC后的组织病理学发现可能因使用的方法而异,并随时间演变;需要进一步研究。